Clinical Testing in State Satisfies Personal Jurisdiction Test, Calif. Federal Judge Rules

SAN FRANCISCO — Clinical testing of a drug performed in California is enough to satisfy the state’s “but for” personal jurisdiction test for determining whether a claim arises out of the drug maker’s forum-related activities, a California federal judge has ruled in a saxagliptin action.

However, in the June 27 order, Judge Jon S. Tigar granted defendants’ alternative motion to transfer the case to the District of South Carolina, finding that “the overwhelming majority of events” directly related to the plaintiff’s alleged injuries took place in that state.

In April, South Carolina resident Ophelia Dubose filed the instant action against …